Orion Oyj B (ORNBV) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.086x

Based on the latest financial reports, Orion Oyj B (ORNBV) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€79.50 Million ≈ $92.94 Million USD) by net assets (€919.60 Million ≈ $1.08 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Orion Oyj B (ORNBV) liquidity interval to measure how many days the company can operate on defensive assets alone.

Orion Oyj B - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Orion Oyj B's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Orion Oyj B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orion Oyj B ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
DISCOVERY LTD(UNSP.ADR)/3
F:D3H0
N/A
AGCO Corporation
NYSE:AGCO
0.167x
Jyske Bank A/S
CO:JYSK
-0.328x
Primo Brands Corporation
NYSE:PRMB
0.035x
Primerica Inc
NYSE:PRI
0.062x
UNICHARM CORP. SP.ADR 1
F:UN41
0.047x
Biomerieux SA
PA:BIM
0.115x
Alpha Services and Holdings S.A.
AT:ALPHA
0.143x

Annual Cash Flow Conversion Efficiency for Orion Oyj B (2000–2024)

The table below shows the annual cash flow conversion efficiency of Orion Oyj B from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Orion Oyj B (ORNBV) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €1.00 Billion
≈ $1.17 Billion
€293.40 Million
≈ $343.02 Million
0.292x +118.37%
2023-12-31 €890.10 Million
≈ $1.04 Billion
€119.00 Million
≈ $139.12 Million
0.134x -72.05%
2022-12-31 €908.10 Million
≈ $1.06 Billion
€434.40 Million
≈ $507.86 Million
0.478x +65.86%
2021-12-31 €747.90 Million
≈ $874.37 Million
€215.70 Million
≈ $252.18 Million
0.288x -29.48%
2020-12-31 €731.30 Million
≈ $854.97 Million
€299.10 Million
≈ $349.68 Million
0.409x +17.72%
2019-12-31 €779.40 Million
≈ $911.20 Million
€270.80 Million
≈ $316.59 Million
0.347x +16.33%
2018-12-31 €773.10 Million
≈ $903.84 Million
€230.90 Million
≈ $269.95 Million
0.299x -11.12%
2017-12-31 €679.70 Million
≈ $794.64 Million
€228.40 Million
≈ $267.02 Million
0.336x -13.52%
2016-12-31 €641.10 Million
≈ $749.51 Million
€249.10 Million
≈ $291.22 Million
0.389x -9.32%
2015-12-31 €594.90 Million
≈ $695.50 Million
€254.90 Million
≈ $298.00 Million
0.428x -25.64%
2014-12-31 €514.90 Million
≈ $601.97 Million
€296.70 Million
≈ $346.87 Million
0.576x +37.60%
2013-12-31 €513.90 Million
≈ $600.80 Million
€215.20 Million
≈ $251.59 Million
0.419x -3.14%
2012-12-31 €511.20 Million
≈ $597.65 Million
€221.00 Million
≈ $258.37 Million
0.432x +8.68%
2011-12-31 €500.00 Million
≈ $584.55 Million
€198.90 Million
≈ $232.54 Million
0.398x -11.08%
2010-12-31 €467.40 Million
≈ $546.44 Million
€209.10 Million
≈ $244.46 Million
0.447x -3.99%
2009-12-31 €439.10 Million
≈ $513.35 Million
€204.60 Million
≈ $239.20 Million
0.466x +35.07%
2008-12-31 €418.60 Million
≈ $489.39 Million
€144.40 Million
≈ $168.82 Million
0.345x +2.25%
2007-12-31 €447.30 Million
≈ $522.94 Million
€150.90 Million
≈ $176.42 Million
0.337x +83.36%
2006-12-31 €443.50 Million
≈ $518.50 Million
€81.60 Million
≈ $95.40 Million
0.184x -38.23%
2005-12-31 €581.80 Million
≈ $680.19 Million
€173.30 Million
≈ $202.61 Million
0.298x -22.89%
2004-12-31 €479.70 Million
≈ $560.82 Million
€185.30 Million
≈ $216.64 Million
0.386x +111.66%
2003-12-31 €597.80 Million
≈ $698.89 Million
€109.10 Million
≈ $127.55 Million
0.183x +17.05%
2002-12-31 €685.60 Million
≈ $801.54 Million
€106.90 Million
≈ $124.98 Million
0.156x -6.00%
2001-12-31 €677.60 Million
≈ $792.19 Million
€112.40 Million
≈ $131.41 Million
0.166x +12.40%
2000-12-31 €668.80 Million
≈ $781.90 Million
€98.70 Million
≈ $115.39 Million
0.148x --

About Orion Oyj B

HE:ORNBV Finland Drug Manufacturers - General
Market Cap
$8.57 Billion
€7.33 Billion EUR
Market Cap Rank
#2554 Global
#10 in Finland
Share Price
€67.35
Change (1 day)
-1.25%
52-Week Range
€56.85 - €75.15
All Time High
€75.15
About

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflam… Read more